셀트리온헬스케어, ‘허쥬마’ 일본 판매 돌입

글 내용 전체보기

FDA approves first drug for neurotrophic keratitis, a rare eye disease

글 내용 전체보기

Does CAR-T Therapy Have a Payment Problem?

글 내용 전체보기

A Glimpse into the Pancreatic Cancer Pipeline

글 내용 전체보기

Novartis’s Breast Cancer Drug Looks Promising in Phase III Trial, Despite Category’s Troubling History

글 내용 전체보기

AstraZeneca COPD Drug Fails to Distinguish Itself from Rival GSK Treatment

글 내용 전체보기

Toxic “Zombie Cells” Observed in Alzheimer’s Patients

글 내용 전체보기

Gritstone and bluebird Ink Deal to Target Tumors With Gene and Cell Therapies

글 내용 전체보기

Pfizer and Astellas Amend Protocols for Prostate Cancer Clinical Trials

글 내용 전체보기

Innovate Biopharmaceuticals Teams Up With CRO for Phase III Celiac Trial

글 내용 전체보기

Judge affirms multibillion-dollar talc verdict against J&J; case set for appeals

글 내용 전체보기

Appeals court tosses case against GlaxoSmithKline over suicide linked to generic Paxil

글 내용 전체보기

After early budget woes, flu-shot expert Seqirus swings to its first-ever profit

글 내용 전체보기

Pfizer, Astellas speed up 2 Xtandi studies in market duel with Johnson & Johnson

글 내용 전체보기

AstraZeneca’s Bevespi takes discouraging hit in head-to-head test against GSK

글 내용 전체보기

Novartis’ PI3K drug hits goal in phase 3 breast cancer trial, laying groundwork for talks with regulators

글 내용 전체보기

Congo approves 4 more experimental Ebola meds to fight outbreak

글 내용 전체보기

GBT picks up Roche’s dropped heart drug for its sickle cell disease pipeline in $127M deal

글 내용 전체보기

Novo Nordisk adds to diabetes pipeline with Evotec deal

글 내용 전체보기

Bluebird taps Gritstone for oncology cell therapy targets

글 내용 전체보기

Accelerator’s ApoGen nets new biochem leaders, plus an additional $4M to target cancer resistance

글 내용 전체보기